Metoprolol


Article Author:
Jason Morris


Article Editor:
Alexis Dunham


Editors In Chief:
Casey Ciresi


Managing Editors:
Avais Raja
Orawan Chaigasame
Khalid Alsayouri
Kyle Blair
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beenish Sohail
Hajira Basit
Phillip Hynes
Sandeep Sekhon


Updated:
12/17/2018 9:16:37 AM

Indications

Metoprolol is FDA-approved for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation/flutter, and hypertension. Off-label uses include supraventricular tachycardia and thyroid storm. Both oral and intravenous preparations are available. There are immediate and extended-release preparations available orally. There is controversy regarding the selection of beta blockers in the management of the above conditions. There also is conflicting evidence regarding the optimal selection of a particular beta blocker in the treatment of each specific disease.[1] The role of beta-blockers as initial therapy for hypertension, particularly in the absence of compelling indications, has been questioned.[2][3] Several randomized trials in the 1980s showed a mortality benefit for beta blockers in acute myocardial infarction.[4][5][6] The Metoprolol Atherosclerosis Prevention in Hypertensives (MAPHY) trial specifically showed a benefit of metoprolol over diuretics regarding sudden cardiac death as well as myocardial infarction.[7] In a large randomized trial of over 50,000 patients in the 1990's, Metoprolol was shown to reduce mortality and re-infarction when used chronically after myocardial infarction.[8]  Beta blockers have been shown to exert prognostic benefit and reduce mortality in the treatment of chronic heart failure. The carvedilol or metoprolol European trial (COMET) enrolled patients with stable heart failure and compared each drug head-to-head. Carvedilol was associated with a statistically significantly lower risk of all-cause death.[9] However, recent trials have had conflicting evidence on whether selective beta-1 blockers such as metoprolol have any benefit over other beta blockers like carvedilol.[1]

Mechanism of Action

Metoprolol is a cardioselective beta-1-adrenergic receptor inhibitor that competitively blocks beta1-receptors with minimal or no effects on beta-2 receptors at oral doses of less than 100 mg in adults. It decreases cardiac output by negative inotropic and chronotropic effects. Metoprolol does not exhibit membrane stabilizing or intrinsic sympathomimetic activity. Administration of metoprolol to normal subjects results in a reduction in heart rate and cardiac output; this appears to be related to the dose and concentration of the drug. Metoprolol is mainly lipophilic, and distribution is typical of a basic lipophilic drug. Based on animal studies, it appears to be almost completely absorbed from the gastrointestinal (GI) tract when taken orally. There is significant hepatic first-pass elimination which results in around 50% of the oral dose reaching systemic circulation. It is 11% bound to serum albumin. The half-life of metoprolol is about 3 to 4 hours in most patients for non-extended release tabs. Metoprolol is principally excreted via the kidneys.[10] Metoprolol succinate produces more level drug concentrations as compared to metoprolol tartrate, which has more peak-to-trough variation. However, despite these differences in pharmacokinetics, studies have concluded that both agents produce similar clinical effects both acute and chronically. [11]

Administration

Metoprolol may be administered orally or intravenously. The immediate-release oral formulation is to be administered with or immediately following food. The short-acting formulation of metoprolol tartrate is usually taken twice daily. It may be effective for hypertension when taken once per day; however, lower doses may not control blood pressure for 24 hours. The extended-release metoprolol succinate formulation may be administered without regard to meals.[12]

Adverse Effects

The primary adverse effects of metoprolol include heart failure exacerbation, fatigue, depression, bradycardia or heart block, hypotension, bronchospasm, cold extremities, dizziness, decreased libido, diarrhea, tinnitus, decreased exercise tolerance, glucose intolerance, and may mask hypoglycemia. Abrupt cessation of the drug may lead to a withdrawal syndrome that could cause angina or myocardial infarction. Tachycardia and hypertension are both common in the withdrawal syndrome.[13]

Contraindications

Metoprolol is contraindicated in patients with sick sinus syndrome, second or third-degree heart block (in the absence of pacemaker),  decompensated heart failure, hypotension, and with documented hypersensitivity to the drug or components. Also, caution must be exercised in patients that have a history of noncompliance as abrupt cessation of the drug can lead to withdrawal syndromes including angina and myocardial infarction. Patients who have ingested cocaine or methamphetamine have traditionally had a contraindication to the use of selective beta-blocker such as metoprolol. This is based on case reports, and there is no strong evidence that they cause any deleterious effects. Regardless, agents such as labetalol, which have alpha and beta activity, or calcium channel blockers should be used in these cases. Metoprolol is a pregnancy risk factor Category C drug.[14]

Monitoring

The onset of action for oral immediate-release tablets is within 1 hour with a duration of effect variable depending on the dose given. The extended-release preparation has a similar onset of action and a duration up to 24 hours. Metabolism of metoprolol is hepatic with excretion in the urine. If there is renal impairment, there is no dosage adjustment necessary. If there is a history of hepatic impairment, slowly increasing titrated doses to effect should be used. With the use of intravenous (IV) administration, cardiac monitor including ECG heart rate and blood pressure should be constant. Oral administration heart rate rhythm and blood pressure should be monitored.[14]

Toxicity

Treatment will vary based on the amount of Metoprolol amount taken, comorbidities, age, and other co-investments. On arrival, assess ABCs and monitor appropriate blood work including coingestants, ECG, large bore IVs, and pregnancy status if female. Consult poison control/toxicology early in the course. Treatment choices include volume resuscitation, activated charcoal, whole bowel irrigation, nasogastric lavage, atropine, glucagon, calcium gluconate/calcium chloride, high-dose insulin, vasopressors, Intralipid, transcutaneous or transvenous pacemaker. Cardiac status and a current fluid balance will guide volume resuscitation. Activated charcoal is typically given 1 g/kg and usually only has efficacy if given within 1 to 2 hours of ingestion.[15] If the patient has any altered mentation, caution must be given secondary to the possibility of aspiration. Whole bowel irrigation should be considered for extended release preparations or large quantity ingestion. Nasogastric lavage is usually ineffective with the exception of large quantity ingestions. The clinician may consider atropine use, although it is typically ineffective in moderate-to-severe overdoses. Calcium administration to increase intracellular calcium at a dose of 60 mg/kg over 5 to 10 minutes of calcium gluconate. Calcium chloride at a dose of 10 to 20 mL of a 10% solution can be used if central access is obtained. Glucagon is given at a dose of 50 mcg/kg as a bolus with titration of drip. High-dose insulin at a dose of 1 unit per kilogram bolus followed by 1 unit per kilogram per hour drip.[16] Administration with dextrose with a drip titrating to euglycemia as well as potassium repletion as needed. Vasopressors with epinephrine or norepinephrine titrated rate and blood pressure. Intralipid, IV lipid emulsion therapy can be considered as a lipid sink that extracts the drug from the myocyte. It is also thought to provide free fatty acids as a substrate. It should be noted that the use of this medication will affect some laboratory monitoring.[17] Consider a transcutaneous or transvenous pacemaker. Extracorporeal membrane oxygenation (ECMO) should be considered for refractory cases.[18] If the clinician is concerned about intentional overdose, they should order a mandatory psychiatric evaluation. There may also be a need for the possibility of co-ingestants and treatment of those as well. For non-extended or non-sustained-release preparations, 4 to 6 hours of observation without any derangement of mental status or vital signs is sufficient. Any extended release or sustained release preparation requires 12 to 24 hours of telemetry observation, depending on the preparation. Extra caution should be considered in the pediatric population as very low amounts, including one pill or even one-half pill, can cause cardiovascular collapse and death.[19]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Metoprolol - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is least likely with the use of metoprolol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which is true regarding metoprolol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
In which of the following drug classes is metoprolol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following beta-blocking agents is not expected to have any effect on bronchial smooth muscles?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following beta-blockers does not have intrinsic sympathomimetic activity?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following beta-blockers would be an appropriate therapy for an asthmatic patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following antagonizes the cardiac effect of metoprolol?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following antihypertensives may cause lipid abnormalities?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following drugs does not interfere with testicular function?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 70-year-old male is admitted for extreme fatigue. He has a heart rate of 50 bpm and a 12-lead EKG reveals a PR interval of 240 msec. Each p wave is followed by a QRS complex. What type of heart block is evident and which home medication is most likely to blame?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
You have a hypertensive patient who is also asthmatic. Which of the following hypertensive agents would be either be contraindicated or used with caution?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient is recovering from an acute myocardial infarction. They have asthma, type 2 diabetes mellitus, and migraine headaches. Which of the following is true regarding metoprolol use in this patient? Select all that apply.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A nurse is providing care to a client admitted 2 days ago for atrial fibrillation with a rapid ventricular response. The healthcare provider ordered metoprolol 5 mg IV slow push now and then 50 mg twice daily by mouth. The nurse's familiarity with the medication is an essential element in clinical judgment and the decision to hold the medication and contact the provider or administer the drug. What actions below indicate the appropriate decision making? Select all that apply.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Metoprolol - References

References

Walter E,McKinlay J,Corbett J,Kirk-Bayley J, Review of management in cardiotoxic overdose and efficacy of delayed intralipid use. Journal of the Intensive Care Society. 2018 Feb     [PubMed]
Chenoweth JA,Colby DK,Sutter ME,Radke JB,Ford JB,Nilas Young J,Richards JR, Massive diltiazem and metoprolol overdose rescued with extracorporeal life support. The American journal of emergency medicine. 2017 Oct     [PubMed]
Stellpflug SJ,Harris CR,Engebretsen KM,Cole JB,Holger JS, Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin. Clinical toxicology (Philadelphia, Pa.). 2010 Mar     [PubMed]
Euwema MS,Swanson TJ, Toxicity, Deadly Single Dose Agents null. 2018 Jan     [PubMed]
Graudins A,Lee HM,Druda D, Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. British journal of clinical pharmacology. 2016 Mar     [PubMed]
Lindholm LH,Carlberg B,Samuelsson O, Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet (London, England). 2005 Oct 29-Nov 4     [PubMed]
Khan N,McAlister FA, Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2006 Jun 6     [PubMed]
Wikstrand J,Warnold I,Tuomilehto J,Olsson G,Barber HJ,Eliasson K,Elmfeldt D,Jastrup B,Karatzas NB,Leer J, Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension (Dallas, Tex. : 1979). 1991 Apr     [PubMed]
Brogden RN,Heel RC,Speight TM,Avery GS, Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs. 1977 Nov     [PubMed]
Fr�hlich H,Zhao J,T�ger T,Cebola R,Schellberg D,Katus HA,Grundtvig M,Hole T,Atar D,Agewall S,Frankenstein L, Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study. Circulation. Heart failure. 2015 Sep     [PubMed]
Wikstrand J,Hjalmarson A,Waagstein F,Fagerberg B,Goldstein S,Kjekshus J,Wedel H, Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). Journal of the American College of Cardiology. 2002 Aug 7     [PubMed]
Remme WJ,Cleland JG,Erhardt L,Spark P,Torp-Pedersen C,Metra M,Komajda M,Moullet C,Lukas MA,Poole-Wilson P,Di Lenarda A,Swedberg K, Effect of carvedilol and metoprolol on the mode of death in patients with heart failure. European journal of heart failure. 2007 Nov     [PubMed]
Kukin ML,Mannino MM,Freudenberger RS,Kalman J,Buchholz-Varley C,Ocampo O, Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure. Journal of the American College of Cardiology. 2000 Jan     [PubMed]
Helfand M,Peterson K,Christensen V,Dana T,Thakurta S, . 2009 Jul     [PubMed]
Ripley TL,Saseen JJ, ?-blockers: a review of their pharmacological and physiological diversity in hypertension. The Annals of pharmacotherapy. 2014 Jun     [PubMed]
Hjalmarson A,Herlitz J,Holmberg S,Ryd�n L,Swedberg K,Vedin A,Waagstein F,Waldenstr�m A,Waldenstr�m J,Wedel H,Wilhelmsen L,Wilhelmsson C, The G�teborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation. 1983 Jun     [PubMed]
Intravenous beta-blockade during acute myocardial infarction. Lancet (London, England). 1986 Jul 12     [PubMed]
Sleight P, Use of beta adrenoceptor blockade during and after acute myocardial infarction. Annual review of medicine. 1986     [PubMed]
Freemantle N,Cleland J,Young P,Mason J,Harrison J, beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ (Clinical research ed.). 1999 Jun 26     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Nurse-Corrections (CCN). The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Nurse-Corrections (CCN), it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Nurse-Corrections (CCN), you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Nurse-Corrections (CCN). When it is time for the Nurse-Corrections (CCN) board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Nurse-Corrections (CCN).